Search

everythinglearnresearchcommunity

for

Search:↓

Hedgehog pathway inhibitors for advanced basal cell carcinoma can cause side effects, but managing them helps maintain treatment.

BMS-470539 reduces skin fibrosis and inflammation.

ZDHHC17 methylation may help treat or identify facial skin aging.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

A woman's hair turned white after taking a cancer drug called dasatinib.

TET enzymes are important for skin and hair development by controlling gene activity in specific areas.

Antizyme slows skin tumor growth by reducing cell growth in mice.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The treatment was ineffective in humans.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Methotrexate treatment often causes hair loss.

The drug combination was safe and showed promise in treating advanced tumors.

SM04755 may be an effective topical treatment for psoriasis.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Letrozole may help prevent seizures by reducing certain hormone levels.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.